Instruments | Cancer stage | Number of patients | Mean (SD) | p-value | ES | RE |
---|---|---|---|---|---|---|
QLU-C10D | I/II | 215 | 0.63 (0.19) | Â | Â | Â |
 | III/IV | 93 | 0.51 (0.26) | <0.001 | 0.53 |  |
FACT-8D | I/II | 215 | 0.65(0.18) | Â | Â | Â |
 | III/IV | 93 | 0.55(0.25) | 0.001 | 0.47 | 1.27 |
Instruments | OHA | Number of patients | Mean (SD) | p-value | ES | RE |
QLU-C10D | Excellent/good | 24 | 0.64 (0.22) | Â | Â | Â |
 | Fair/poor/very poor | 284 | 0.29 (0.25) | <0.001 | 1.49 |  |
FACT-8D | Excellent/good | 24 | 0.66(0.19) | Â | Â | Â |
 | Fair/poor/very poor | 284 | 0.32(0.29) | <0.001 | 1.42 | 1.48 |
Instruments | ECOG | Number of patients | Mean (SD) | p-value | ES | RE |
QLU-C10D | Grade 0/1 | 219 | 0.70 (0.18) | Â | Â | Â |
 | Grade 2–4 | 89 | 0.40 (0.23) | <0.001 | 1.46 |  |
FACT-8D | Grade 0/1 | 219 | 0.69(0.16) | Â | Â | Â |
 | Grade 2–4 | 89 | 0.49(0.27) | <0.001 | 0.93 | 2.45 |
Instruments | Mental health | Number of patients | Mean (SD) | p-value | ES | RE |
QLU-C10D | Low risk/relatively low risk | 187 | 0.71 (0.18) | Â | Â | Â |
 | Relatively high risk/high risk | 121 | 0.47 (0.24) | <0.001 | 1.14 |  |
FACT-8D | Low risk/relatively low risk | 187 | 0.73 (0.14) | Â | Â | Â |
 | Relatively high risk/high risk | 121 | 0.48 (0.23) | <0.001 | 1.35 | 0.71 |